The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new antibody treatment ...

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published ...

Key Takeaways An antibody treatment effectively protects babies against RSV infectionThe treatment reduced the risk of hospitalization by 83%U.S. babies enjoyed better protection because treatment ...

Babies treated with nirsevimab had an 83% reduced risk of hospitalization due to RSV infection, researchers reported May 1 in The Lancet Child & Adolescent Health. The antibody treatment also ...

The treatment reduced the risk of hospitalization by 83% U.S. babies enjoyed better protection because treatment was prioritized for high-risk infants TUESDAY, May 6, 2025 (HealthDay News ...